MyOme Presents New Data on an Integrated Polygenic Risk Score to Improve Coronary Artery Disease Prediction at the American College of Medical Genetics and Genomics Annual Meeting READ MORE.

“Preimplantation Genetic Testing Could be Informed by Whole-Genome Reconstruction, Study Shows” — GenomeWeb

“The ability to assess disease-related polygenic scores and rare variants in preimplantation embryos may be improved through whole-genome reconstruction (WGR) informed by embryo genotypes and parental genome sequences, according to new research by a team from MyOme, Natera, the Columbia University Irving Medical Center, and Spring Fertility.“

Read full article here…

MyOme, Inc. 535 Middlefield Road, Menlo Park, CA 94025 I www.myome.com
Back to News

Contact Us

We are happy to answer any questions. Contact us at with any questions or to keep apprised of any development, provide your name and email information.

OFFICE and LAB: Menlo Park, California 

Linkedin
© 2023 Myome.com
Myome is not responsible for the content or accuracy of third-party websites
The MyOme Personal Genome Report was developed, and its performance characteristics were determined, by MyOme, Inc., a clinical laboratory certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high complexity clinical laboratory testing. This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary for laboratory-developed tests.